These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311 [TBL] [Abstract][Full Text] [Related]
5. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China. Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220 [TBL] [Abstract][Full Text] [Related]
7. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches. McMahon DJ; Gleeson JP; O'Reilly S; Bambury RM Med Oncol; 2022 Jun; 39(9):129. PubMed ID: 35716200 [TBL] [Abstract][Full Text] [Related]
8. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime. Teo M; Martin S; Owusu-Agyemang K; Nowicki S; Clark B; Mackinnon M; Stewart W; Paul J; St George J Br J Neurosurg; 2014 Jun; 28(3):351-5. PubMed ID: 24111708 [TBL] [Abstract][Full Text] [Related]
11. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073 [TBL] [Abstract][Full Text] [Related]
12. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789 [TBL] [Abstract][Full Text] [Related]
13. Current Immunotherapies for Glioblastoma Multiforme. Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H Front Immunol; 2020; 11():603911. PubMed ID: 33767690 [TBL] [Abstract][Full Text] [Related]
14. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme. Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862 [TBL] [Abstract][Full Text] [Related]
15. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993 [TBL] [Abstract][Full Text] [Related]
16. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy. Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290 [TBL] [Abstract][Full Text] [Related]
17. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials. Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225 [TBL] [Abstract][Full Text] [Related]
18. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Kauer TM; Figueiredo JL; Hingtgen S; Shah K Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831 [TBL] [Abstract][Full Text] [Related]
19. Current Approaches and Challenges in the Molecular Therapeutic Targeting of Glioblastoma. Mooney J; Bernstock JD; Ilyas A; Ibrahim A; Yamashita D; Markert JM; Nakano I World Neurosurg; 2019 Sep; 129():90-100. PubMed ID: 31152883 [TBL] [Abstract][Full Text] [Related]
20. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]